Market closed
Integra LifeSciences/$IART
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Integra LifeSciences
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Ticker
$IART
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
3,946
Website
IART Metrics
BasicAdvanced
$1.7B
Market cap
-
P/E ratio
-$0.08
EPS
1.08
Beta
-
Dividend rate
Price and volume
Market cap
$1.7B
Beta
1.08
52-week high
$45.42
52-week low
$16.81
Average daily volume
735K
Financial strength
Current ratio
1.205
Quick ratio
0.585
Long term debt to equity
90.339
Total debt to equity
130.876
Interest coverage (TTM)
2.92%
Management effectiveness
Return on assets (TTM)
3.06%
Return on equity (TTM)
-0.42%
Valuation
Price to revenue (TTM)
1.078
Price to book
1.11
Price to tangible book (TTM)
-2.09
Price to free cash flow (TTM)
-392.998
Growth
Revenue change (TTM)
1.45%
Earnings per share change (TTM)
-106.88%
3-year revenue growth (CAGR)
0.85%
3-year earnings per share growth (CAGR)
-67.83%
What the Analysts think about IART
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Integra LifeSciences stock.
IART Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
IART Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
IART News
AllArticlesVideos
Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
GlobeNewsWire·1 month ago
Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Integra LifeSciences Reports Third Quarter 2024 Financial Results
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Integra LifeSciences stock?
Integra LifeSciences (IART) has a market cap of $1.7B as of December 22, 2024.
What is the P/E ratio for Integra LifeSciences stock?
The price to earnings (P/E) ratio for Integra LifeSciences (IART) stock is 0 as of December 22, 2024.
Does Integra LifeSciences stock pay dividends?
No, Integra LifeSciences (IART) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Integra LifeSciences dividend payment date?
Integra LifeSciences (IART) stock does not pay dividends to its shareholders.
What is the beta indicator for Integra LifeSciences?
Integra LifeSciences (IART) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.